Confocal Microscopy Evaluation of Margin Clearance in Basal Cell Carcinomas in Mohs Surgery
FCM-P
Does Ex-vivo Fluorescence Confocal Microscopy Allow Faster Evaluation of Margin Clearance in Basal Cell Carcinomas in Mohs Surgery: A Pilot Study
1 other identifier
interventional
30
1 country
1
Brief Summary
This study is comparing the accuracy and speed of the Vivascope 2500 ex-vivo fluorescent confocal microscope with frozen section Mohs histology in evaluating clear margins in basal cell carcinoma in Mohs surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 12, 2017
CompletedFirst Submitted
Initial submission to the registry
July 26, 2018
CompletedFirst Posted
Study publicly available on registry
August 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 9, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 9, 2018
CompletedNovember 27, 2019
November 1, 2019
1.2 years
July 26, 2018
November 25, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To compare the specificity and sensitivity of the ex-vivo fluorescence confocal microscopy against frozen section histopathology in detecting residual BCC in Mohs excisions.
Compare the specificity and sensitivity of the ex-vivo fluorescence confocal microscopy against frozen section histopathology in detecting residual BCC in Mohs excisions.
1 DAY
Secondary Outcomes (1)
To compare the time taken for processing and interpretation of the ex-vivo fluorescence confocal microscopy against frozen section histopathology in detecting residual BCC in Mohs excisions.
1 DAY
Study Arms (1)
ARM A
EXPERIMENTALVivascope 2500 ex-vivo fluorescent confocal microscope
Interventions
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Patient with basal cell carcinoma on the head and neck undergoing Mohs surgery with frozen sections
- Patient willing and able to give informed consent
- Patient treated not previously or currently treated with a hedgehog inhibitor medication (vismodegib)
- Patient suitable for Mohs surgery
- Excised lesion suitable for scanning with FCM as determined by investigator -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Julie Dawsonlead
- Mavig GmbHcollaborator
Study Sites (1)
Norfolk & Norwich University Hospitals NHS Foundation Trust
Norwich, Norfolk, NR4 7UY, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eunice Tan, Consultant
Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Research Services Manager
Study Record Dates
First Submitted
July 26, 2018
First Posted
August 1, 2018
Study Start
June 12, 2017
Primary Completion
August 9, 2018
Study Completion
August 9, 2018
Last Updated
November 27, 2019
Record last verified: 2019-11